Home / Healthcare / Pharmaceutical / North America Cutaneous T-Cell Lymphoma (CTCL) Therapeutics Market

North America Cutaneous T-Cell Lymphoma (CTCL) Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Histone Deacetylase (HDAC) Inhibitors, Monoclonal Antibody, Antineoplastic Agent, and Others), By Disease Type (Mycosis Fungoides (MF), Sezary Syndrome (SS), and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies), and Regional Forecasts, 2021-2028

Report Format: PDF | Latest Update: Sep, 2022 | Published Date: Feb, 2022 | Report ID: FBI106325 | Status : Published
  • North America
  • 2020
  • 73
  • PRICE
  • $ 3850
    $ 4850
    $ 5850
    Buy Now

Healthcare Clients